CAPTRUST Financial Advisors
CLVS

CAPTRUST Financial Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30
Closed – – 4538
2022
Q2 		$0 Hold
30
– – ﹤0.01% 5264
2022
Q1 		$0 Hold
30
– – ﹤0.01% 5261
2021
Q4 		$0 Hold
30
– – ﹤0.01% 5025
2021
Q3 		$0 Sell
30
-352
-92% -$1.7K ﹤0.01% 4851
2021
Q2 		$2K Buy
382
+352
+1,173% +$2.06K ﹤0.01% 4236
2021
Q1 		$0 Buy
+30
New +$201 ﹤0.01% 4538

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAPTRUST Financial Advisors's CLVS Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 30 shares.

CAPTRUST Financial Advisors first reported a position in CLVS in Q1 2021 and held it in 6 quarters. The position peaked at $2K in Q2 2021. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 30 Clovis Oncology, Inc. shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in Clovis Oncology, Inc. in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Clovis Oncology, Inc. position peaked at $2K in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.